Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results

This study was conducted to investigate the feasibility and survival benefits of combined treatment with radiotherapy and temozolomide (TMZ), which has been covered by the national health insurance in Japanese patients with glioblastoma since September 2006. Between September 2006 and December 2011,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Oike, Takahiro, Suzuki, Yoshiyuki, Sugawara, Ken-ichi, Shirai, Katsuyuki, Noda, Shin-ei, Tamaki, Tomoaki, Nagaishi, Masaya, Yokoo, Hideaki, Nakazato, Yoichi, Nakano, Takashi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2013
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3827088/
https://ncbi.nlm.nih.gov/pubmed/24265731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0078943
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller